» Articles » PMID: 28842273

Oxidative Stress and Cellular Pathways of Asthma and Inflammation: Therapeutic Strategies and Pharmacological Targets

Overview
Journal Pharmacol Ther
Specialty Pharmacology
Date 2017 Aug 27
PMID 28842273
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is a complex inflammatory disease characterized by airway inflammation and hyperresponsiveness. The mechanisms associated with the development and progression of asthma have been widely studied in multiple populations and animal models, and these have revealed involvement of various cell types and activation of intracellular signaling pathways that result in activation of inflammatory genes. Significant contributions of Toll-like-receptors (TLRs) and transcription factors such as NF-кB, have been reported as major contributors to inflammatory pathways. These have also recently been associated with mechanisms of oxidative biology. This is of important clinical significance as the observed inefficacy of current available treatments for severe asthma is widely attributed to oxidative stress. Therefore, targeting oxidizing molecules in conjunction with inflammatory mediators and transcription factors may present a novel therapeutic strategy for asthma. In this review, we summarize TLRs and NF-кB pathways in the context of exacerbation of asthma pathogenesis and oxidative biology, and we discuss the potential use of polyphenolic flavonoid compounds, known to target these pathways and possess antioxidant activity, as potential therapeutic agents for asthma.

Citing Articles

Dihydromyricetin Alleviated Acetaminophen-Induced Acute Kidney Injury via Nrf2-Dependent Anti-Oxidative and Anti-Inflammatory Effects.

Shi J, Peng X, Huang J, Zhang M, Wang Y Int J Mol Sci. 2025; 26(5).

PMID: 40076982 PMC: 11899924. DOI: 10.3390/ijms26052365.


Oxidative stress in asthma pathogenesis: mechanistic insights and implications for airway smooth muscle dysfunction.

Li K, Ji X, Tian S, Li J, Tian Y, Ma X Cell Tissue Res. 2025; .

PMID: 39918765 DOI: 10.1007/s00441-025-03953-7.


Association of oxidative balance scores with cardiovascular and all cause mortality in patients with asthma.

Zhao W, Sun Y, Zhu B Sci Rep. 2025; 15(1):3901.

PMID: 39890876 PMC: 11785945. DOI: 10.1038/s41598-025-87996-4.


Oxidative Stress and Antioxidants in Pediatric Asthma's Evolution and Management.

Ioniuc I, Lupu A, Dragan F, Tarnita I, Alexoae M, Streanga V Antioxidants (Basel). 2024; 13(11).

PMID: 39594473 PMC: 11590961. DOI: 10.3390/antiox13111331.


Serum Derivatives-Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma-COPD Overlap: A Prospective Study.

Nakamoto K, Watanabe M, Saito M, Kasuga K, Miyaoka C, Yoshida Y J Clin Med. 2024; 13(19).

PMID: 39408083 PMC: 11477913. DOI: 10.3390/jcm13196022.


References
1.
Camargo Jr C, Gurner D, Smithline H, Chapela R, Fabbri L, Green S . A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol. 2010; 125(2):374-80. DOI: 10.1016/j.jaci.2009.11.015. View

2.
Brasier A . The NF-kappaB regulatory network. Cardiovasc Toxicol. 2007; 6(2):111-30. DOI: 10.1385/ct:6:2:111. View

3.
Hollingsworth 2nd J, Cook D, Brass D, Walker J, Morgan D, Foster W . The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med. 2004; 170(2):126-32. DOI: 10.1164/rccm.200311-1499OC. View

4.
Bochkov Y, Hanson K, Keles S, Brockman-Schneider R, Jarjour N, Gern J . Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 2009; 3(1):69-80. PMC: 2884103. DOI: 10.1038/mi.2009.109. View

5.
Barnes P, Ito K, Adcock I . Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet. 2004; 363(9410):731-3. DOI: 10.1016/S0140-6736(04)15650-X. View